Hospital Vega Baja-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2023

  1. Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat

    Patient Preference and Adherence, Vol. 17, pp. 839-849

2022

  1. Role of vericiguat in the overall etiopathogenesis of heart failure with reduced ejection fraction. Current position

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 8-14

  2. Therapeutic approach to patients with heart failure with reduced ejection fraction. The role of vericiguat

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 23-29

  3. Vericiguat in heart failure: from scientific evidence to clinical practice

    Revista Clinica Espanola

  4. Vericiguat in heart failure: from scientific evidence to clinical practice

    Revista Clinica Espanola, Vol. 222, Núm. 6, pp. 359-369